You have 9 free searches left this month | for more free features.

City

Singapore (2)

Boston (1)

Nagoya (1)

Nashville (1)

Sarasota (1)

Tokyo (1)

Condition

Acute Lymphoid Leukemia (1)

Acute Myeloid Leukemia (1)

Advanced Cancer (1)

Chronic Myeloid Leukemia (1)

Malignant Solid Tumour (1)

Multiple Myeloma (1)

Nasopharyngeal Carcinoma (1)

Non-Hodgkin Lymphoma (1)

Overall Status

Completed (3)

Terminated (1)

Sign in for free

Phase

phase 1 (4)

Sponsor

National University Hospital, Singapore (1)

Otsuka Beijing Research Institute (1)

Otsuka Pharmaceutical Co., Ltd. (1)

Otsuka Pharmaceutical Development & Commercialization, Inc. (1)

Collaborator

Otsuka Pharmaceutical Co., Ltd. (1)

Shin Nippon Biomedical Laboratories, Ltd. (1)

Intervention

opb-51602 (4)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

opb-51602

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Nasopharyngeal Carcinoma Trial in Singapore (OPB-51602)

Terminated

Nasopharyngeal Carcinoma

OPB-51602

Singapore, Singapore

National University Hospital, Singapore

Jun 17, 2015

Multiple Myeloma, Non-Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in Nagoya, Tokyo (OPB-51602)

Completed

Has Results

Multiple Myeloma
+4 more

OPB-51602

Nagoya, Japan
+1 more

May 20, 2015

Malignant Solid Tumour Trial in Singapore (OPB-51602)

Completed

Malignant Solid Tumour

OPB-51602

Singapore, Singapore
+1 more

Mar 24, 2014

Advanced Cancer Trial in Sarasota, Boston, Nashville (OPB-51602)

Completed

Advanced Cancer

OPB-51602

Sarasota, Florida
+2 more

Jan 14, 2014